Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders Equity (Deficit) (Unaudited)

v3.19.3
Condensed Consolidated Statements of Stockholders Equity (Deficit) (Unaudited) - USD ($)
Total
Series A Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2017   0 41,529,181    
Beginning balance at Dec. 31, 2017 $ 3,511,564 $ 0 $ 41,529 $ 107,760,036 $ (104,290,001)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock (in shares)     14,697,110    
Issuance of common stock 16,398,662   $ 12,728 16,385,934  
Shared based compensation 803,227     803,227  
Net loss (18,812,656)       (18,812,656)
Stock options and warrants exercised (in shares)     44,643    
Stock options and warrants exercised 90,065   $ 45 90,020  
Warrant exchange     1,969 (1,969)  
Deemed dividend       765,179 (765,179)
Ending balance at Sep. 30, 2018 1,990,862 $ 0 $ 56,271 125,802,427 (123,867,836)
Ending balance (in shares) at Sep. 30, 2018   0 56,270,934    
Beginning balance (in shares) at Jun. 30, 2018   0 45,003,219    
Beginning balance at Jun. 30, 2018 (5,155,869) $ 0 $ 45,003 113,181,411 (118,382,283)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock (in shares)     11,267,715    
Issuance of common stock 12,377,321   $ 11,268 12,366,053  
Shared based compensation 254,963     254,963  
Net loss (5,485,553)       (5,485,553)
Ending balance at Sep. 30, 2018 1,990,862 $ 0 $ 56,271 125,802,427 (123,867,836)
Ending balance (in shares) at Sep. 30, 2018   0 56,270,934    
Beginning balance (in shares) at Dec. 31, 2018   0 58,270,934    
Beginning balance at Dec. 31, 2018 (15,422,443) $ 0 $ 58,271 126,076,782 (141,557,496)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock (in shares)     7,183,488    
Issuance of common stock 5,928,235   $ 7,184 5,921,051  
Shared based compensation 1,211,629     1,211,629  
Net loss (37,817,959)        
Stock options and warrants exercised (in shares)     517,224    
Stock options and warrants exercised 1,973   $ 517 1,456  
Deemed dividend (in shares)     116,496    
Deemed dividend     $ 116 86,091 (86,207)
Common stock issued for payment of series B preferred stock dividend (in shares)     101,471    
Common stock issued for payment of series B preferred stock dividend, value 166,771   $ 102 166,669  
Value of warrants issued with preferred stock 6,709,961     6,709,961  
Effect of reclassification of warrants 857,072     857,072  
Ending balance at Sep. 30, 2019 (38,364,761) $ 0 $ 66,190 141,030,711 (179,461,662)
Ending balance (in shares) at Sep. 30, 2019   0 66,189,613    
Beginning balance (in shares) at Jun. 30, 2019   0 66,081,812    
Beginning balance at Jun. 30, 2019 (27,374,629) $ 0 $ 66,082 140,527,364 (167,968,075)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shared based compensation 334,711     334,711  
Net loss (11,493,587)       (11,493,587)
Stock options and warrants exercised (in shares)     6,330    
Stock options and warrants exercised 1,973   $ 6 1,967  
Common stock issued for payment of series B preferred stock dividend (in shares)     101,471    
Common stock issued for payment of series B preferred stock dividend, value 166,771   $ 102 166,669  
Ending balance at Sep. 30, 2019 $ (38,364,761) $ 0 $ 66,190 $ 141,030,711 $ (179,461,662)
Ending balance (in shares) at Sep. 30, 2019   0 66,189,613